Statement of Organization, Functions, and Delegations of Authority, 42326-42327 [2014-17126]
Download as PDF
42326
•
•
•
•
•
•
Federal Register / Vol. 79, No. 139 / Monday, July 21, 2014 / Notices
Æ Change in dietary or nutrient intake
(i.e., energy intake, saturated fat
consumption)
Æ Adherence to treatment, including
self-monitoring and medication
Clinical outcomes
Æ Glycemic control (Hemoglobin Alt)
Æ Change in body composition (i.e.,
weight, Body Mass Index, waist
circumference, % body fat)
Æ Episodes of severe hypoglycemia
Æ Treatment for hyperglycemia
(ketoacidosis)
Æ Control of blood pressure and
lipids
Æ Development or control of
depression or anxiety
Health outcomes
Æ Quality of life (e.g., validated tools
for health-related quality of life, life
satisfaction, psychosocial
adaptation to illness, patient
satisfaction)
Æ Development of micro- and
macrovascular complications (i.e.,
retinopathy, nephropathy,
neuropathy, cardiovascular
outcomes)
Æ Mortality (all-cause)
Diabetes-related health care
utilization
Æ Hospital admissions
Æ Length of stay in hospital
Æ Emergency department admissions
Æ Visits to specialist clinics
Program acceptability as measured by
participant attrition rates
Harms from program as reported for
studies
Activity-related injury
Timing
Any length of followup
emcdonald on DSK67QTVN1PROD with NOTICES
Settings
• Community health setting (i.e.,
ambulatory care clinics, outpatient
clinics, primary care clinics, family
physician clinics, Community
Health Centers, Rural Health
Centers)
• United States or other high-income
countries with a very high Human
Development Index
Key Questions 5–6
Population
Adults (≥18 years) with T2DM who have
undergone primary diabetes
education
17:14 Jul 18, 2014
• Multicomponent behavioral programs
that include at least one of:
Æ Diabetes self-management
education; OR
Æ Structured dietary intervention
(related to any of weight loss,
glycemic control, or reducing risk
for complications) together with
one or more additional components;
OR
Æ Structured exercise/physical
activity intervention together with
one or more additional components.
Æ Additional components may
include interventions related to:
diet or physical activity, behavioral
change (including but not limited
to: Goal setting, problem solving,
motivational interviewing, coping
skills training, cognitive behavioral
therapy strategies), relaxation or
stress reduction, blood glucose
awareness, medication adherence,
or self-monitoring for diabetic
complications (foot, eye, and renal
tests).
• Repeated provision by one or more
trained individuals
• Duration of intervention: Minimum 4
weeks
Jkt 232001
macrovascular complications (i.e.,
retinopathy, nephropathy,
neuropathy, cardiovascular
outcomes)
Æ Mortality (all-cause)
• Diabetes-related health care
utilization
Æ Hospital admissions
Æ Length of stay in hospital
Æ Emergency department admissions
Æ Visits to specialist clinics
• Program acceptability as measured by
participant attrition rates
Timing
Any length of followup
Study design
Randomized controlled trials
Settings
• Community health setting (i.e.,
ambulatory care clinics, outpatient
clinics, primary care clinics, family
physician clinics, Community
Health Centers, Rural Health
Centers)
• United States or other high-income
country with a very high Human
Development Index
Language
Comparators
English
• Usual or standard care or an active
comparator (e.g., behavioral
program or intervention) as
reported for studies
• Delivery methods (personnel,
intensity, communication methods
etc.) as reported for studies
Dated: July 3, 2014.
Richard Kronick,
AHRQ Director.
Outcomes
Study Design
Prospective comparative studies using a
best evidence approach based on
hierarchy of evidence: randomized
controlled trials, nonrandomized
controlled trials, prospective cohort
studies, controlled before-after
studies
VerDate Mar<15>2010
Interventions
• Behavioral outcomes
Æ Change in physical activity (e.g.,
volume of activity per week) or
fitness (e.g., cardiorespiratory
fitness, strength)
Æ Change in dietary or nutrient intake
(i.e., energy intake, saturated fat
consumption)
Æ Adherence to medication
• Clinical outcomes
Æ Glycemic control (Hemoglobin Mc)
Æ Change in body composition (i.e.,
weight, Body Mass Index, waist
circumference, % body fat)
Æ Control of blood pressure and
lipids
Æ Sleep apnea or sleep quality
Æ Development or control of
depression or anxiety
• Health outcomes
Æ Quality of life (e.g., validated tools
for health-related quality of life, life
satisfaction, psychosocial
adaptation to illness, patient
satisfaction)
Æ Development of micro- and
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
[FR Doc. 2014–16669 Filed 7–18–14; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Statement of Organization, Functions,
and Delegations of Authority
Part E, Chapter E (Agency for
Healthcare Research and Quality), of the
Statement of Organization, Functions,
and Delegations of Authority for the
Department of Health and Human
Services (61 FR 15955–58, April 10,
1996, most recently amended at 78 FR
38981, on June 28, 2013) is amended to
reflect recent organizational changes.
The specific amendments are as follows:
I. Under Section E–10, Organization,
delete all components and replace with
the following:
A. Office of the Director.
B. Center for Delivery, Organization,
and Markets.
C. Center for Financing, Access, and
Cost Trends.
D. Center for Evidence and Practice
Improvement.
E:\FR\FM\21JYN1.SGM
21JYN1
emcdonald on DSK67QTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 139 / Monday, July 21, 2014 / Notices
E. Center for Quality Improvement
and Patient Safety.
F. Office of Communications and
Knowledge Transfer.
G. Office of Extramural Research,
Education, and Priority Populations.
H. Office of Management Services.
II. Under Section E–20, Functions,
delete Center for Outcomes and
Evidence (EJ) and Center for Primary
Care, Prevention, and Clinical
Partnerships (EK) in its entirety and
replace with the following:
Center for Evidence and Practice
Improvement (EK). Generates new
knowledge, synthesizes evidence,
translates science for multiple
stakeholders, and catalyzes practice
improvement. Specifically: (1) Conducts
and supports evidence synthesis and
research on health care delivery and
improvement that is informed by the
needs of patients, clinicians, and policy
makers, including providing scientific,
administrative and dissemination
support for the U.S. Preventive Services
Task Force; (2) advances decision and
communication sciences and
implementation research to facilitate
informed treatment and health care
decision making by patients and their
health care providers and serving as a
trusted source for evidence-based tools,
decision aids, and other products about
what works in health care and practice
improvement; (3) explores how health
information technology can improve
clinical decision making and health care
quality and helping Federal partners
and health care stakeholders use this
evidence; (4) catalyzes and sustains
ongoing improvements in clinical
practice across health care settings
through research, demonstration
projects, and partnership development;
(5) operates the National Center for
Excellence in Primary Care Research.
Division of the Evidence-Based
Practice Center Program (EKB).
Produces evidence syntheses by
conducting systematic evidence reviews
using robust and rigorous
methodologies to advance the methods
of evidence synthesis to ensure
scientific rigor and unbiased reviews of
evidence.
Division of U.S. Preventive Services
Task Force Support (EKC). Provides
scientific, administrative, and
dissemination support for the
independent U.S. Preventive Services
Task Force, enabling the Task Force to
make evidence-based recommendations
on clinical preventive services.
Division of Decision Science and
Patient Engagement (EKD). Provides
evidence-based tools, decision aids, and
other products that address what works
in health care and practice
VerDate Mar<15>2010
17:14 Jul 18, 2014
Jkt 232001
improvement. Specifically: (1)
Translates complex scientific evidence
into tools and products targeted to
diverse stakeholders that facilitate
informed health care decision making
and (2) engages with stakeholders to
advance the field of evidence-based
decision making to improve methods for
engagement of all communities in
health care decision making.
Division of Health Information
Technology (EKE). Develops and
disseminates evidence and evidencebased tools to inform policy and
practice on how health information
technology can improve the quality of
health care.
Division of Practice Improvement
Science and Implementation (EKF).
Engages stakeholders and communities
of learning for practice improvement,
serves as a trusted resource of evidence
and tools for methods, measures, and
evaluation of practice improvement.
Specifically: (1) Explores how to
facilitate practice transformation and
improvement in diverse settings and (2)
pilots innovative models of practice
improvement.
All delegations and redelegations of
authority to officers and employees of
the Agency for Healthcare Research and
Quality that were in effect immediately
prior to the effective date of this
reorganization shall continue in effect
pending further redelegation provided
they are consistent with this
reorganization.
These changes are effective upon date
of signature.
Dated: July 9, 2014.
Richard Kronick,
AHRQ Director.
[FR Doc. 2014–17126 Filed 7–18–14; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–14–14YK]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
42327
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Information Collection on CauseSpecific Absenteeism in Schools—
New—National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Division of Global Migration and
Quarantine (DGMQ), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Division of Global
Migration and Quarantine (DGMQ),
requests approval of a new information
collection to better understand the
triggers, timing and duration of the use
of school related measures for
preventing and controlling the spread of
influenza during the next pandemic.
The information collection for which
approval is sought is in accordance with
DGMQ/CDC’s mission to reduce
morbidity and mortality in mobile
populations, and to prevent the
introduction, transmission, or spread of
communicable diseases within the
United States. Insights gained from this
information collection will assist in the
E:\FR\FM\21JYN1.SGM
21JYN1
Agencies
[Federal Register Volume 79, Number 139 (Monday, July 21, 2014)]
[Notices]
[Pages 42326-42327]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-17126]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Statement of Organization, Functions, and Delegations of
Authority
Part E, Chapter E (Agency for Healthcare Research and Quality), of
the Statement of Organization, Functions, and Delegations of Authority
for the Department of Health and Human Services (61 FR 15955-58, April
10, 1996, most recently amended at 78 FR 38981, on June 28, 2013) is
amended to reflect recent organizational changes. The specific
amendments are as follows:
I. Under Section E-10, Organization, delete all components and
replace with the following:
A. Office of the Director.
B. Center for Delivery, Organization, and Markets.
C. Center for Financing, Access, and Cost Trends.
D. Center for Evidence and Practice Improvement.
[[Page 42327]]
E. Center for Quality Improvement and Patient Safety.
F. Office of Communications and Knowledge Transfer.
G. Office of Extramural Research, Education, and Priority
Populations.
H. Office of Management Services.
II. Under Section E-20, Functions, delete Center for Outcomes and
Evidence (EJ) and Center for Primary Care, Prevention, and Clinical
Partnerships (EK) in its entirety and replace with the following:
Center for Evidence and Practice Improvement (EK). Generates new
knowledge, synthesizes evidence, translates science for multiple
stakeholders, and catalyzes practice improvement. Specifically: (1)
Conducts and supports evidence synthesis and research on health care
delivery and improvement that is informed by the needs of patients,
clinicians, and policy makers, including providing scientific,
administrative and dissemination support for the U.S. Preventive
Services Task Force; (2) advances decision and communication sciences
and implementation research to facilitate informed treatment and health
care decision making by patients and their health care providers and
serving as a trusted source for evidence-based tools, decision aids,
and other products about what works in health care and practice
improvement; (3) explores how health information technology can improve
clinical decision making and health care quality and helping Federal
partners and health care stakeholders use this evidence; (4) catalyzes
and sustains ongoing improvements in clinical practice across health
care settings through research, demonstration projects, and partnership
development; (5) operates the National Center for Excellence in Primary
Care Research.
Division of the Evidence-Based Practice Center Program (EKB).
Produces evidence syntheses by conducting systematic evidence reviews
using robust and rigorous methodologies to advance the methods of
evidence synthesis to ensure scientific rigor and unbiased reviews of
evidence.
Division of U.S. Preventive Services Task Force Support (EKC).
Provides scientific, administrative, and dissemination support for the
independent U.S. Preventive Services Task Force, enabling the Task
Force to make evidence-based recommendations on clinical preventive
services.
Division of Decision Science and Patient Engagement (EKD). Provides
evidence-based tools, decision aids, and other products that address
what works in health care and practice improvement. Specifically: (1)
Translates complex scientific evidence into tools and products targeted
to diverse stakeholders that facilitate informed health care decision
making and (2) engages with stakeholders to advance the field of
evidence-based decision making to improve methods for engagement of all
communities in health care decision making.
Division of Health Information Technology (EKE). Develops and
disseminates evidence and evidence-based tools to inform policy and
practice on how health information technology can improve the quality
of health care.
Division of Practice Improvement Science and Implementation (EKF).
Engages stakeholders and communities of learning for practice
improvement, serves as a trusted resource of evidence and tools for
methods, measures, and evaluation of practice improvement.
Specifically: (1) Explores how to facilitate practice transformation
and improvement in diverse settings and (2) pilots innovative models of
practice improvement.
All delegations and redelegations of authority to officers and
employees of the Agency for Healthcare Research and Quality that were
in effect immediately prior to the effective date of this
reorganization shall continue in effect pending further redelegation
provided they are consistent with this reorganization.
These changes are effective upon date of signature.
Dated: July 9, 2014.
Richard Kronick,
AHRQ Director.
[FR Doc. 2014-17126 Filed 7-18-14; 8:45 am]
BILLING CODE 4160-90-P